PHC GROUPPHC Holdings Corporation

  • About Us
  • Group Companies
  • Products & Services
  • CSR
  • Investor Relations

About Us

Corporate Overview History Our Culture Leadership

Group Companies

Ascensia Epredia PHCbi Medicom LSI Medience

Products & Services

Cancer Pathology Biologic & Cell Preservation Diagnostic Testing Patient Record & Billing Software Diabetes Management Medical Device & Drug Delivery

CSR

CORPORATE INTEGRITY

  • Code of Conduct
  • Corporate Governance
  • Risk Management
  • Information Security
  • CSR Procurement
  • Developing Quality Products
  • Customer Satisfaction

PEOPLE INSIGHTS

  • Human Rights Policy
  • Promoting Diversity
  • Work Style Reform
  • Developing Human Resources
  • Creating a Safe & Healthy Workplace

ENVIRONMENTAL SUSTAINABILITY

  • Environmental Activities

SOCIAL RESPONSIBILITY

  • Solving Problems through Business
  • Regional Social Action Programs
  • COVID-19 Response

Investor Relations

INVESTOR RELATIONS

MANAGEMENT

  • Corporate Governance
  • IR Basic Policy

IR LIBRARY

  • Financial Results
  • Presentation Materials
  • IR Materials

STOCK INFORMATION

  • Stock Overview
  • General Meeting of Shareholders
  • Stock Quotations
IR News Financial Highlights IR Calendar Contact IR Disclaimer
NewsroomCareersContact
JP

Other PHC Group Websites

  • PHC Corporation
  • Ascensia Diabetes Care
  • Epredia
  • LSI Medience Corporation
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • PHC Medicom Corporation
  • PHC Corporation (Shanghai) Ltd.
  • SciMed(Asia)Pte Ltd
  • Amelieff Corporation

Other PHC Group Websites

  • PHC Corporation
  • Ascensia Diabetes Care
  • Epredia
  • LSI Medience Corporation
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • PHC Medicom Corporation
  • PHC Corporation (Shanghai) Ltd.
  • SciMed(Asia)Pte Ltd
  • Amelieff Corporation
NewsroomCareersContactJP
Newsroom > 2021 > Company Operations in Response to Lifting of COVID-19 Imposed State of Emergency.

News


2021

AnnouncementMarch 22

Company Operations in Response to Lifting of COVID-19 Imposed State of Emergency.

Our sincere condolences to victims of COVID-19, and we hope for the quick recovery of those who have been infected. We also offer sincere gratitude towards healthcare professionals on the forefront to treat patients, and everyone helping to support the community infrastructure.

Responding to the Japanese Government’s March 19 decision to lift the state of emergency in four prefectures, PHC Holdings Corporation (headquarters: Tokyo, Japan) will be reopening the company sites from March 23. However, as we prioritize the safety of customers and employees, employees of the reopening sites will continue to work from home in principle. At other sites in Japan, employees will also continue to work from home as much as possible. When a customer visit is required, upon receipt of the customer’s consent, the visiting employee will strictly implement infection prevention measures such as temperature measurement, wearing of face masks, hand-washing, etc.

· Site reopening

PHC Holdings Corporation Shimbashi Headquarters (Address: 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo)
PHC Corporation Shimbashi Headquarters (Address: 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo)
[Biomedical Business Unit]
 Tokyo Sales Office/Pharmacy System Sales Office/Delicart Sales Office (address as above)
 South Kanto Sales Office (Address: 1-16-32-106 Fujigaoka, Aoba-ku, Yokohama City, Kanagawa)
[Medical Information Systems Business Unit]
 East Japan Sales Office (Address: 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo)
 Shibuya Business Transformation Center (Address: Tokyo Tatemono Shibuya Building 7F, 3-9-9 Shibuya, Shibuya-ku, Tokyo)
 Omiya Office (Address: Wellness Cube Omiya 3/4F, 1-853-8 Miyahara-cho, Kita-ku, Saitama City, Saitama)
[Anatomical Pathology Business Unit]
 Shinkoyasu Manufacturing Site (Address: 3-9 Moriya-cho, Kanagawa-ku, Yokohama City, Kanagawa)
 CS Repair Warehouse (Address: 3-22-16 Nishikojiya, Ota-ku, Tokyo)
Shonan Health Innovation Park Office (Address: Shonan Health Innovation Park B33F-4110, 34-10 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa)

The health and safety of our customers, patients, employees and their families are most important to us and we will continue to further strengthen measures to prevent internal and external spread of the infection, while working to ensure stable supply for customers and patients who rely on our products and services.

Media contact

Corporate Communications Group
PHC Holdings Corporation
+81-3-6778-5311

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
Terms of UsePrivacy PolicyFacebookLinkedIn © PHC Holdings Corporation All rights reserved.